Digital Trends & Insights: February 2026 – A pharmaphorum industry r... February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.
Digital Trends & Insights, January 2026: A pharmaphorum industry rep... Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.
Digital Agentic AI: The shift from R&D to R&P will deliver the first... The next two years will be defined by a shift from R&D (Research & Development) to R&P (Research & Prediction), facilitated by agentic AI.
Digital Key trends shaping pharmaceutical operations in 2025 2025 will be a challenging year for many sectors with multiple headwinds, and the pharmaceutical industry is no exception.
R&D Pharma holds it breath for ’25 as the sun shines on JP Morga... The JP Morgan Healthcare Conference is seen as a barometer for the life sciences industry – and, going into this year’s event, the forecast for the year was particularly grim.
Oncology Life Sciences Industry Report - Oncology Developments in the oncology space in 2024 brought hope to both industry and patients.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.